These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 11195255)
21. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373 [TBL] [Abstract][Full Text] [Related]
22. Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders. de Haan L; Beuk N; Hoogenboom B; Dingemans P; Linszen D J Clin Psychiatry; 2002 Feb; 63(2):104-7. PubMed ID: 11874209 [TBL] [Abstract][Full Text] [Related]
23. Reduced short-term obsessive-compulsive symptoms in schizophrenic patients treated with risperidone: a single-blind prospective study. Veznedaroglu B; Ercan ES; Kayahan B; Varan A; Bayraktar E Hum Psychopharmacol; 2003 Dec; 18(8):635-40. PubMed ID: 14696023 [TBL] [Abstract][Full Text] [Related]
24. Obsessive-compulsive symptoms in patients with schizophrenia: a naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients. Scheltema Beduin AA; Swets M; Machielsen M; Korver N; J Clin Psychiatry; 2012 Nov; 73(11):1395-402. PubMed ID: 23218156 [TBL] [Abstract][Full Text] [Related]
25. [Metabolic side effects of risperidone in early onset schizophrenia]. Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267 [TBL] [Abstract][Full Text] [Related]
27. Use of atypical neuroleptics in child and adolescent psychiatry. Toren P; Laor N; Weizman A J Clin Psychiatry; 1998 Dec; 59(12):644-56. PubMed ID: 9921698 [TBL] [Abstract][Full Text] [Related]
28. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia. Möller HJ; Riedel M; Jäger M; Wickelmaier F; Maier W; Kühn KU; Buchkremer G; Heuser I; Klosterkötter J; Gastpar M; Braus DF; Schlösser R; Schneider F; Ohmann C; Riesbeck M; Gaebel W Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670 [TBL] [Abstract][Full Text] [Related]
29. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients. Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740 [TBL] [Abstract][Full Text] [Related]
30. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone. Aman MG; Gharabawi GM; J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046 [TBL] [Abstract][Full Text] [Related]
31. Novel uses for risperidone: focus on depressive, anxiety and behavioral disorders. Ravindran AV; Bradbury C; McKay M; da Silva TL Expert Opin Pharmacother; 2007 Aug; 8(11):1693-710. PubMed ID: 17685886 [TBL] [Abstract][Full Text] [Related]
32. Risperidone for the treatment of behavioral and psychological symptoms of dementia. Tune LE J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986 [TBL] [Abstract][Full Text] [Related]
33. Treatment of special populations with the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations. J Clin Psychiatry; 1998; 59 Suppl 12():46-52. PubMed ID: 9766620 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of atypical antipsychotics in elderly patients with dementia. Tariot PN; Profenno LA; Ismail MS J Clin Psychiatry; 2004; 65 Suppl 11():11-5. PubMed ID: 15264966 [TBL] [Abstract][Full Text] [Related]
35. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice. Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165 [TBL] [Abstract][Full Text] [Related]
36. Risperidone treatment of bipolar mania. Nguyen LN; Guthrie SK Ann Pharmacother; 2006 Apr; 40(4):674-82. PubMed ID: 16569811 [TBL] [Abstract][Full Text] [Related]
37. Risperidone as monotherapy for a patient with obsessive compulsive disorder comorbid with schizoaffective disorder: a case report. Chiou YJ; Lin PY; Lee Y Clin Neuropharmacol; 2015; 38(3):114-6. PubMed ID: 25970281 [TBL] [Abstract][Full Text] [Related]
38. Atypical antipsychotics for disruptive behaviour disorders in children and youths. Loy JH; Merry SN; Hetrick SE; Stasiak K Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123 [TBL] [Abstract][Full Text] [Related]
40. Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness. Keith S Expert Rev Neurother; 2009 Jan; 9(1):9-31. PubMed ID: 19102665 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]